Synthetic route to anti-viral agents

US9809576B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9809576-B1
Application numberUS-201514802372-A
CountryUS
Kind codeB1
Filing dateJul 17, 2015
Priority dateJul 18, 2014
Publication dateNov 7, 2017
Grant dateNov 7, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.

First claim

Opening claim text (preview).

We claim: 1. A method comprising one or more of steps A, C, D, E, E′, F, F′, G, G′, H, I, J, K, L, M, and N: (A) wherein the reaction takes place in a sixteenth solvent, thereby forming a thirteenth product mixture comprising (C) wherein Step 1 of the reaction takes place in a thirteenth solvent in the presence of a seventh base; and Step 2 of the reaction takes place in a fourteenth solvent, thereby forming an eleventh product mixture comprising (D) wherein the reaction takes place in a twelfth solvent in the presence of a second acid, thereby forming a tenth product mixture comprising (E) wherein the reaction takes place in an eleventh solvent in the presence of a sixth base, thereby forming a ninth product mixture comprising (E′) wherein step (1) takes place in a nineteenth solvent in the presence of an eighth base, and step (2) takes place in a twentieth solvent in the presence of a ninth base, thereby forming a sixteenth product mixture comprising (F) wherein the reaction takes place in a tenth solvent in the presence of a fifth base, thereby forming an eighth product mixture comprising (F′) wherein the reaction takes place in a eighteenth solvent in the presence of a reagent, thereby forming an fifteenth product mixture comprising (G) wherein the reaction takes place in a ninth solvent in the presence of a fourth base, thereby forming a seventh product mixture comprising (G′) wherein the reaction takes place in a seventeenth solvent in the presence of an oxidant, thereby forming a fourteenth product mixture comprising (H) wherein the reaction takes place in an eighth solvent, thereby forming a sixth product mixture comprising (I) wherein Step 1 of the reaction takes place in a sixth solvent at a sixth temperature to effect a Claisen rearrangement, and Step 2 of the reaction takes place in a seventh solvent at a seventh temperature, thereby forming a fifth product mixture comprising (J) wherein the reaction takes place in a fifth solvent in the presence of a first acid and a hydrogen source, thereby forming a fourth product mixture comprising (K) wherein Step 1 of the reaction takes place in a third solvent in the presence of a second base; and Step 2 of the reaction takes place in a fourth solvent in the presence of a third base, thereby forming a third product mixture comprising (L) wherein the reaction takes place in a second solvent in the presence of a first enzyme, thereby forming a second product mixture comprising (M) wherein the reaction takes place in a first solvent in the presence of a first base, thereby forming a first product mixture comprising or (N) wherein: LG is a leaving group; and the second reagent comprises one or more reagents sufficient to replace the OH with group LG. 2. The method of claim 1 , comprising the reaction of Scheme N, wherein LG is Br, and the second reagent comprises PPh 3 and Br 2 .

Assignees

Inventors

Classifications

  • by esterification of carboxylic acid groups in the enantiomers or the inverse reaction · CPC title

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring · CPC title

  • from amines with formation of carbamate groups · CPC title

  • with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9809576B1 cover?
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Who is the assignee on this patent?
Abbvie Inc
What technology area does this patent fall under?
Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).